Envestnet Asset Management Inc Grifols Sa Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Grifols Sa stock. As of the latest transaction made, Envestnet Asset Management Inc holds 256,215 shares of GRFS stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

256,215

Previous 227,030 12.86%

Holding current value

$2.43 Million

Previous $1.43 Million 59.09%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$6.28 - $9.38 $183,281 - $273,755	29,185 Added 12.86%	256,215 $2.28 Million
Q2 2024 Aug 08, 2024	SELL	$6.27 - $7.7 $70,901 - $87,071	-11,308 Reduced 4.74%	227,030 $1.43 Million
Q1 2024 May 13, 2024	BUY	$5.47 - $11.38 $1,334 - $2,776	244 Added 0.1%	238,338 $1.59 Million
Q4 2023 Feb 13, 2024	BUY	$7.71 - $11.56 $244,715 - $366,914	31,740 Added 15.38%	238,094 $2.75 Million
Q3 2023 Nov 13, 2023	BUY	$8.91 - $10.91 $1.04 Million - $1.27 Million	116,694 Added 130.15%	206,354 $1.89 Million
Q2 2023 Aug 04, 2023	SELL	$7.14 - $9.29 $521,826 - $678,959	-73,085 Reduced 44.91%	89,660 $821,000
Q1 2023 May 11, 2023	BUY	$6.65 - $10.69 $792,965 - $1.27 Million	119,243 Added 274.11%	162,745 $1.2 Million
Q4 2022 Feb 07, 2023	SELL	$5.96 - $8.53 $36,481 - $52,212	-6,121 Reduced 12.34%	43,502 $369,000
Q3 2022 Nov 10, 2022	SELL	$5.95 - $14.3 $625,047 - $1.5 Million	-105,050 Reduced 67.92%	49,623 $306,000
Q2 2022 Aug 03, 2022	BUY	$10.6 - $13.28 $264,819 - $331,774	24,983 Added 19.26%	154,673 $1.84 Million
Q1 2022 May 04, 2022	BUY	$10.37 - $12.73 $337,533 - $414,348	32,549 Added 33.51%	129,690 $1.52 Million
Q4 2021 Feb 04, 2022	SELL	$10.21 - $15.27 $486,547 - $727,676	-47,654 Reduced 32.91%	97,141 $1.09 Million
Q3 2021 Oct 07, 2021	SELL	$14.07 - $17.3 $405,835 - $499,001	-28,844 Reduced 16.61%	144,795 $2.12 Million
Q2 2021 Aug 04, 2021	SELL	$16.62 - $18.94 $8.28 Million - $9.44 Million	-498,221 Reduced 74.16%	173,639 $3.01 Million
Q1 2021 May 04, 2021	SELL	$15.15 - $19.78 $621,059 - $810,861	-40,994 Reduced 5.75%	671,860 $11.6 Million
Q4 2020 Feb 02, 2021	SELL	$16.86 - $19.67 $764,482 - $891,896	-45,343 Reduced 5.98%	712,854 $13.1 Million
Q3 2020 Oct 09, 2020	SELL	$15.4 - $20.16 $2.11 Million - $2.77 Million	-137,238 Reduced 15.33%	758,197 $13.2 Million
Q2 2020 Jul 08, 2020	BUY	$18.24 - $21.45 $485,913 - $571,428	26,640 Added 3.07%	895,435 $16.3 Million
Q1 2020 Apr 23, 2020	SELL	$16.28 - $25.63 $863,930 - $1.36 Million	-53,067 Reduced 5.76%	868,795 $17.5 Million
Q4 2019 Feb 11, 2020	SELL	$19.57 - $23.52 $3.48 Million - $4.18 Million	-177,638 Reduced 16.16%	921,862 $21.5 Million
Q3 2019 Oct 17, 2019	BUY	$19.85 - $22.76 $176,684 - $202,586	8,901 Added 0.82%	1,099,500 $22 Million
Q2 2019 Aug 02, 2019	BUY	$17.59 - $21.1 $701,137 - $841,046	39,860 Added 3.79%	1,090,599 $23 Million
Q1 2019 May 10, 2019	BUY	$18.01 - $20.11 $506,026 - $565,030	28,097 Added 2.75%	1,050,739 $21.1 Million
Q4 2018 Feb 13, 2019	BUY	$17.44 - $21.53 $5.4 Million - $6.67 Million	309,855 Added 43.47%	1,022,642 $18.8 Million
Q3 2018 Nov 14, 2018	BUY	$19.97 - $21.96 $9.11 Million - $10 Million	456,223 Added 177.82%	712,787 $15.2 Million
Q2 2018 Aug 10, 2018	BUY	$20.16 - $24.68 $2.96 Million - $3.62 Million	146,616 Added 133.35%	256,564 $5.51 Million
Q1 2018 May 09, 2018	SELL	$20.31 - $24.95 $1.44 Million - $1.77 Million	-70,809 Reduced 39.17%	109,948 $2.33 Million
Q4 2017 Feb 20, 2018	BUY	$20.99 - $23.89 $229,567 - $261,284	10,937 Added 6.44%	180,757 $4.14 Million
Q3 2017 Nov 13, 2017	BUY	$20.07 - $21.89 $111,709 - $121,839	5,566 Added 3.39%	169,820 $3.72 Million
Q2 2017 Aug 14, 2017	BUY	N/A	164,254	164,254 $3.47 Million

Others Institutions Holding GRFS

# of Institutions

162

Shares Held

140M

Call Options Held

288K

Put Options Held

389K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $6.43B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Grifols Sa Transaction History